Lupin launches generic Topicort, gets tentative OK for generic Cialis

Press enter to search
Close search
Open Menu

Lupin launches generic Topicort, gets tentative OK for generic Cialis

By Sandra Levy - 07/27/2018
Lupin has received the Food and Drug Administration’s approval for desoximetasone topical spray in a 0.25% dosage strength.

Lupin’s product is the generic equivalent of Taro Pharmaceuticals’ Topicort topical Spray 0.25%. It is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years old or older.

The product has a market value of approximately $18.7 million, according to IQVIA data.

In a separate development, Lupin announced that it has received tentative approval from the FDA for a generic version of Eli Lilly’s Cialis (tadalafil) tablets in 2.5-mg, 5-mg, 10-mg, and 20-mg dosage strengths.

Tadalafil is indicated for erectile dysfunction; the signs and symptoms of benign prostatic hyperplasia; and erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia.

The product has a market value of approximately $1949.2 million, according to IQVIA data.

Related Topics